MedTrace Logo

A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension

NCT00241007 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 836

Last updated 2011-11-08

No results posted yet for this study

Summary

SAFETY EXTENSION STUDY TO THE CORE STUDY CVAH631C2301

Conditions

Interventions

DRUG

VALSARTAN, VALSARTAN+HYDROCHLOROTHIAZIDE

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2005-03-31
Completion
2005-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00241007 on ClinicalTrials.gov